Screener
iRadimed IRMD EV / EBITDA
EV / EBITDA at other companies
Other financials
Where this comes from
Calculated from iRadimed’s reported figures.
Based on the most recent quarter.
The source filing: iRadimed’s 10-Q, filed May 1, 2026. Open the filing →
- Filed
- May 1, 2026, 4:08 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-029325
FAQ
- What is iRadimed's EV / EBITDA?
- iRadimed (IRMD) reported EV / EBITDA of 26.3× in Q1 2025.
- How has iRadimed's EV / EBITDA changed year-over-year?
- iRadimed's EV / EBITDA increased by 10.6% year-over-year, from 23.8× to 26.3×.
- What is the long-term trend for iRadimed's EV / EBITDA?
- Over 2 years (2021 to 2024), iRadimed's EV / EBITDA has grown at a -21.1% compound annual growth rate (CAGR), from 45.5× to 28.3×.
- What does EV / EBITDA mean?
- Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.
Ask your AI about iRadimed's ev / ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude